List view / Grid view
9 May 2011 | By Pfizer
Pfizer Inc. announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine...
9 May 2011 | By Merck
Aim is to increase awareness, prevention and diagnosis of HCV infection....
6 May 2011 | By Cephalon Inc
Cephalon, Inc. presented positive results from a phase IV trial...
6 May 2011 | By Abbott
Abbott announced that the FDA approved the RX ACCULINK® Carotid Stent System...
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
5 May 2011 | By kdm communications limited
Exclusive license to develop and commercialize new technology...
5 May 2011 | By The Scott Partnership
Novozymes Biopharma, unveiled its enhanced next-generation albumin technology...
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
5 May 2011 | By Peter Huber Kältemaschinenbau GmbH
Huber Ministats are the smallest cooling thermostats in the world! Despite their size Ministats have enough power...
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
5 May 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. has extended its funding support of the Gilead Sciences Research Centre at the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague...
4 May 2011 | By The Scott Partnership
ERT, has appointed Jeffrey S. Litwin, as its new President and Chief Executive Officer and as a member of the board...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new upgrade program that includes the donation of reconditioned Thermo Scientific NanoDrop 1000 spectrophotometers to academic institutions in developing countries.
3 May 2011 | By OgilvyHealthPR
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy…
2 May 2011 | By Cephalon, Inc.
Teva will acquire all of the outstanding shares of Cephalon for a total enterprise value of approximately $6.8 billion...
